{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:49:22Z","timestamp":1793260162602,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10072-026-08818-7","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:03:13Z","timestamp":1769493793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Timing of anticoagulation therapy in patients with acute ischemic stroke and atrial fibrillation: a GRADE-based expert opinion recommendation"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5123-2459","authenticated-orcid":false,"given":"Emanuele","family":"Spina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Romoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giulia","family":"Mosconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Padroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Canavero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Mannino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Zedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Paciaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"8818_CR1","doi-asserted-by":"publisher","unstructured":"Alrohimi A, Jickling G, Buck B, Butcher KS (2023) Timing of anticoagulation after acute ischemic stroke in patients with atrial fibrillation. Can J Neurol Sci 50(4):503\u2013514.\u00a0https:\/\/doi.org\/10.1017\/cjn.2022.268","DOI":"10.1017\/cjn.2022.268"},{"key":"8818_CR2","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1161\/01.STR.14.5.688","volume":"14","author":"RG Hart","year":"1983","unstructured":"Hart RG, Coull BM, Hart D (1983) Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study. Stroke 14:688\u2013693","journal-title":"Stroke"},{"key":"8818_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/01.STR.0000254600.92975.1f","volume":"38","author":"M Paciaroni","year":"2007","unstructured":"Paciaroni M, Agnelli G, Micheli S, Caso V (2007) Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke 38:423\u2013430","journal-title":"Stroke"},{"issue":"2","key":"8818_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1474-4422(18)30356-9","volume":"18","author":"DJ Seiffge","year":"2019","unstructured":"Seiffge DJ, Werring DJ, Paciaroni M et al (2019) Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. Lancet Neurol 18(2):117\u2013126","journal-title":"Lancet Neurol"},{"key":"8818_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981\u2013992","journal-title":"N Engl J Med"},{"key":"8818_CR6","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139\u20131151","journal-title":"N Engl J Med"},{"key":"8818_CR7","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369:2093\u20132104","journal-title":"N Engl J Med"},{"key":"8818_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883\u2013891","journal-title":"N Engl J Med"},{"key":"8818_CR9","unstructured":"Societ\u00e0 Italiana di Neurologia Linee guida SPREAD \u2013 VIII edizione. https:\/\/isa-aii.com\/linee-guida-spread-viii-edizione\/ - Sintesi 11.5.e"},{"issue":"3","key":"8818_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/2396987319841187","volume":"4","author":"CJM Klijn","year":"2019","unstructured":"Klijn CJM, Paciaroni M, Berge E et al (2019) Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: a European Stroke Organisation guideline. Eur Stroke J 4(3):198\u2013223","journal-title":"Eur Stroke J"},{"issue":"5","key":"8818_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2020","unstructured":"Hindricks G, Potpara T, Dagres N et al (2020) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association of Cardio-Thoracic surgery (EACTS). Eur Heart J 42(5):373\u2013498","journal-title":"Eur Heart J"},{"key":"8818_CR12","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1093\/eurheartj\/eht134","volume":"34","author":"H Heidbuchel","year":"2013","unstructured":"Heidbuchel H, Verhamme P, Alings M et al (2013) EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J 34:2094\u20132106","journal-title":"Eur Heart J"},{"issue":"7","key":"8818_CR13","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S et al (2021) 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the American heart association\/American stroke association. Stroke 52(7):e364\u2013e467","journal-title":"Stroke"},{"key":"8818_CR14","doi-asserted-by":"crossref","unstructured":"Toyoda K, Arihiro S, Todo K, SAMURAI Study Investigators et al (2015) Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study. Int J Stroke 10:836\u2013842","DOI":"10.1111\/ijs.12452"},{"key":"8818_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/1747493016632239","volume":"11","author":"S Arihiro","year":"2016","unstructured":"Arihiro S, Todo K, Koga M et al (2016) SAMURAI study Investigators. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: the SAMURAI-Nonvalvular atrial fibrillation (NVAF) study. Int J Stroke 11:565\u2013574","journal-title":"Int J Stroke"},{"key":"8818_CR16","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1253\/circj.CJ-18-0067","volume":"82","author":"S Yoshimura","year":"2018","unstructured":"Yoshimura S, Koga M, Sato S et al (2018) SAMURAI study Investigators. Two-Year outcomes of anticoagulation for acute ischemic stroke with nonvalvular atrial fibrillation: SAMURAI-NVAF study. Circ J 82:1935\u20131942","journal-title":"Circ J"},{"key":"8818_CR17","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.01.035","volume":"25","author":"M Yasaka","year":"2016","unstructured":"Yasaka M, Minematsu K, Toyoda K et al (2016) Design and rationale of the RELAXED study. J Stroke Cerebrovasc Dis 25:1342\u20131348","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"8818_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212354","volume":"14","author":"M Yasaka","year":"2019","unstructured":"Yasaka M, Minematsu K, Toyoda K et al (2019) Rivaroxaban administration after acute ischemic stroke: the RELAXED study. PLoS One 14:e0212354","journal-title":"PLoS One"},{"key":"8818_CR19","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/STROKEAHA.115.008891","volume":"46","author":"M Paciaroni","year":"2015","unstructured":"Paciaroni M, Agnelli G, Falocci N et al (2015) Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study. Stroke 46:2175\u20132182","journal-title":"Stroke"},{"key":"8818_CR20","doi-asserted-by":"publisher","first-page":"e007034","DOI":"10.1161\/JAHA.117.007034","volume":"6","author":"M Paciaroni","year":"2017","unstructured":"Paciaroni M, Agnelli G, Falocci N et al (2017) Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) study. J Am Heart Assoc 6:e007034","journal-title":"J Am Heart Assoc"},{"key":"8818_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1474-4422(18)30145-5","volume":"17","author":"D Wilson","year":"2018","unstructured":"Wilson D, Ambler G, Shakeshaft C et al (2018) CROMIS-2 collaborators. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2). Lancet Neurol 17:539\u2013547","journal-title":"Lancet Neurol"},{"key":"8818_CR22","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1212\/WNL.0000000000003283","volume":"87","author":"DJ Seiffge","year":"2016","unstructured":"Seiffge DJ, Traenka C, Polymeris A et al (2016) Early start of DOAC after ischemic stroke: risk of intracranial hemorrhage and recurrent events. Neurology 87:1856\u20131862","journal-title":"Neurology"},{"key":"8818_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11239-016-1393-9","volume":"42","author":"M Cappellari","year":"2016","unstructured":"Cappellari M, Carletti M, Danese A et al (2016) Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation. J Thromb Thrombolysis 42:393\u2013398","journal-title":"J Thromb Thrombolysis"},{"key":"8818_CR24","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.06.031","volume":"25","author":"K Macha","year":"2016","unstructured":"Macha K, Volbers B, Bobinger T et al (2016) Early initiation of anticoagulation with direct oral anticoagulants in patients after transient ischemic attack or ischemic stroke. J Stroke Cerebrovasc Dis 25:2317\u20132321","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"8818_CR25","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1161\/STROKEAHA.121.036695","volume":"53","author":"S Kimura","year":"2022","unstructured":"Kimura S, Yoshimoto T, Toyoda K et al (2022) Practical \u20181-2-3-4-Day\u2019 rule for starting direct oral anticoagulants after ischemic stroke with atrial fibrillation: combined Hospital-Based cohort study. Stroke 53(5):1540\u20131549","journal-title":"Stroke"},{"issue":"2","key":"8818_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/jnnp-2021-327236","volume":"93","author":"GM De Marchis","year":"2022","unstructured":"De Marchis GM, Seiffge DJ, Schaedelin S et al (2022) Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis. J Neurol Neurosurg Psychiatry 93(2):119\u2013125","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8818_CR27","doi-asserted-by":"crossref","unstructured":"Oldgren J, \u00c5sberg S, Hijazi Z, National TIMING Collaborators et al (2022) Early versus delayed non\u2013vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study. Circulation 146(14):1056\u20131066","DOI":"10.1161\/CIRCULATIONAHA.122.060666"},{"issue":"26","key":"8818_CR28","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","volume":"388","author":"U Fischer","year":"2023","unstructured":"Fischer U, Koga M, Strbian D et al (2023) Early versus later anticoagulation for stroke with atrial fibrillation. N Engl J Med 388(26):2411\u20132421","journal-title":"N Engl J Med"},{"issue":"10482","key":"8818_CR29","first-page":"927","volume":"403","author":"DJ Werring","year":"2024","unstructured":"Werring DJ, Dehbi HM, Ahmed N et al (2024) Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, open-label, blinded-endpoint, phase 4, randomised controlled trial. Lancet 403(10482):927\u2013936","journal-title":"Lancet"},{"issue":"5","key":"8818_CR30","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2025.0285","volume":"82","author":"SJ Warach","year":"2025","unstructured":"Warach SJ, Davis LA, Lawrence P et al (2025) Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation: A Pragmatic, Response-Adaptive randomized clinical trial. JAMA Neurol 82(5):470\u2013476","journal-title":"JAMA Neurol"},{"key":"8818_CR31","doi-asserted-by":"publisher","first-page":"645822","DOI":"10.3389\/fneur.2021.645822","volume":"12","author":"A Alrohimi","year":"2021","unstructured":"Alrohimi A, Jickling G, Jeerakathil T et al (2021) Protocol for LASER: A randomized evaluation and an associated registry of early anticoagulation with Edoxaban after ischemic stroke in patients with atrial fibrillation. Front Neurol 12:645822","journal-title":"Front Neurol"},{"issue":"10","key":"8818_CR32","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/STROKEAHA.115.010049","volume":"46","author":"R von Kummer","year":"2015","unstructured":"von Kummer R, Broderick JP, Campbell BCV et al (2015) The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke 46(10):2981\u20132986","journal-title":"Stroke"},{"issue":"10434","key":"8818_CR33","first-page":"933","volume":"403","author":"H-M Dehbi","year":"2025","unstructured":"Dehbi H-M, Fischer U, \u00c5sberg S, Milling TJ, Abend S, Ahmed N et al (2025) Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST). Lancet 403(10434):933\u2013942","journal-title":"Lancet"},{"issue":"24","key":"8818_CR34","first-page":"1804","volume":"149","author":"R Rohner","year":"2024","unstructured":"Rohner R, Goeldlin M, Hakim A et al (2024) Early versus late initiation of direct oral anticoagulants after ischemic stroke in patients with atrial fibrillation and hemorrhagic transformation: a post hoc analysis of the ELAN randomized clinical trial. Circulation 149(24):1804\u20131814","journal-title":"Circulation"},{"issue":"7","key":"8818_CR35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaneurol.2024.1450","volume":"81","author":"MB Goeldlin","year":"2024","unstructured":"Goeldlin MB, Hakim A, Branca M et al (2024) Early vs late anticoagulation in Minor, Moderate, and major ischemic stroke with atrial fibrillation: post hoc analysis of the ELAN randomized clinical trial. JAMA Neurol 81(7):693\u2013702","journal-title":"JAMA Neurol"},{"issue":"4","key":"8818_CR36","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1177\/23969873241251931","volume":"9","author":"L Palaiodimou","year":"2024","unstructured":"Palaiodimou L, Stefanou MI, Katsanos AH et al (2024) Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis. Eur Stroke J 9(4):885\u2013895","journal-title":"Eur Stroke J"},{"issue":"3","key":"8818_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.hrthm.2024.12.008","volume":"22","author":"L Fu","year":"2025","unstructured":"Fu L, Hu J, Yang P, Chen Q (2025) Early versus later non\u2013vitamin K antagonist oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation: a meta-analysis and systematic review of randomized trials. Heart Rhythm 22(3):629\u2013636","journal-title":"Heart Rhythm"},{"key":"8818_CR38","unstructured":"Sandset EC, de Sousa DA (2024) Optimal anticoagulation timing after ischaemic stroke in patients with atrial fibrillation. Lancet S0140\u20136736(24):02259\u20131.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/39491868\/"},{"key":"8818_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.hest.2025.09.006","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhu X, Wang L (2025) Early anticoagulation in HI-1 hemorrhagic transformationafter AF-associated stroke: a randomized trial. Hemorrhagic Stroke. https:\/\/doi.org\/10.1016\/j.hest.2025.09.006","journal-title":"Hemorrhagic Stroke"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08818-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-08818-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08818-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:03:18Z","timestamp":1771347798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-08818-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["8818"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-08818-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not needed as the procedures were performed according to current guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Informed consent"}},{"value":"Ethical approval was not sought for the present study because every patient was treated according to the current standard of care. This study was completed in accordance with the Helsinki Declaration as revised in 2013.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval"}},{"value":"The Authors declare that there is no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflicting interests"}}],"article-number":"206"}}